Urinary Bladder, Overactive clinical trials
The registry lists 854 studies for Urinary Bladder, Overactive across more than 10 countries. 124 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-21.
Status
- Completed
- 512
- Status unknown
- 109
- Recruiting
- 75
- Terminated
- 67
- Not yet recruiting
- 41
- Withdrawn
- 26
Phase
- Phase 4
- 145
- Phase 3
- 109
- Phase 2
- 85
- Phase 1
- 59
- Early Phase 1
- 8
Where
- United States
- 323
- Korea, Republic of
- 64
- Canada
- 60
- United Kingdom
- 60
- Taiwan
- 56
- Belgium
- 54
Who runs them
Astellas Pharma Inc (42) · Pfizer (39) · Allergan (26) · Astellas Pharma Europe B.V. (12) · Pamukkale University (12) · Far Eastern Memorial Hospital (11) · National Taiwan University Hospital (11) · Bayer (11)
Studies
Recruiting first, then most recently updated. Showing 50 of 854 — search for more.
- Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive BladderRecruitingNCT07540273Not applicable1 country
- Sacral Neuromodulation for Male Overactive Bladder (MOAB)RecruitingNCT06511141Not applicable1 country
- PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OABRecruitingNCT06789406Not applicable2 countries
- Aquarius Pilot Study to Evaluate the New Axonics Trial SystemRecruitingNCT07335484Not applicable2 countries
- Tensi+ for Treating Overactive BladderRecruitingNCT07300904Not applicable2 countries
- Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation TherapyRecruitingNCT07662824Not applicable1 country
- Cefar URO - Symptomatic Treatment of Overactive BladderRecruitingNCT06659536Not applicable1 country
- Peroneal Neuromodulation vs Pelvic Floor Exercises in OABNot yet recruitingNCT07788560Not applicable1 country
- Non-invasive Saphenous Nerve Stimulation Therapy for Overactive BladderNot yet recruitingNCT07780786Phase 32 countries
- Impact of Transcutaneous Electrical Nerve Stimulation on the Autonomic Nervous System in the Treatment of Overactive BladderNot yet recruitingNCT07781033Not applicable
- RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive BladderRecruitingNCT07553065Phase 21 country
- Transcranial Direct Current Stimulation for Neurogenic Overactive Bladder Symptoms Among People With StrokeNot yet recruitingNCT07768137Not applicable1 country
- Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA InjectionRecruitingNCT06953271Phase 41 country
- Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive BladderNot yet recruitingNCT077735321 country
- Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety?RecruitingNCT07740629Not applicable1 country
- Treatment Efficacy for Overactive Bladder: Comparing Education, Biofeedback, and Nerve StimulationNot yet recruitingNCT07744620Not applicable1 country
- Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsRecruitingNCT07648290Early Phase 11 country
- Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in WomenNot yet recruitingNCT07739550Not applicable1 country
- Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After StrokeNot yet recruitingNCT07740668Not applicable1 country
- Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive BladderRecruitingNCT07366918Not applicable1 country
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson DiseaseNot yet recruitingNCT07187466Phase 41 country
- Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled StudyNot yet recruitingNCT07711808Phase 4
- Pretibial TENS for Pain and Anxiety During Intravesical OnabotulinumtoxinA InjectionNot yet recruitingNCT07707791Not applicable
- Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)RecruitingNCT07195656Not applicable1 country
- BTL Emsella Chair Versus Sham for the Treatment of Overactive BladderRecruitingNCT04873037Not applicable1 country
- Zinc Supplementation With Botulinum Toxin for Overactive BladderRecruitingNCT07405554Phase 21 country
- Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in ChildrenNot yet recruitingNCT06769854Phase 4
- A Novel Wearable Transcutaneous Tibial Nerve Stimulation (TTNS) Device in the Treatment of Patients With Overactive Bladder (OAB) and NocturiaNot yet recruitingNCT07635251Not applicable1 country
- Efficacy of Probiotics for OAB Patients With AnxietyNot yet recruitingNCT07635212Not applicable1 country
- Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)RecruitingNCT06551246Phase 31 country
- Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson DiseaseNot yet recruitingNCT07627529Phase 41 country
- Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder SymptomsRecruitingNCT05878951Phase 2/31 country
- INOPASE - Performance and Safety Study of a Personalised SNM SystemRecruitingNCT07193407Not applicable1 country
- Impact of TTNS on Bladder Symptoms Among People With MS, A RCTRecruitingNCT06341673Not applicable1 country
- The Effectiveness of Transcutaneous Sacral Neuromodulation Techniques-Magnetic Stimulation and Electrical Stimulation-on Detrusor Overactivity in Patients With Spinal Cord InjuryRecruitingNCT07578532Not applicable1 country
- Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of LifeNot yet recruitingNCT07545148
- Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral NeuromodulationRecruitingNCT06434831Not applicable1 country
- Add-On ZIDA Sock Therapy for Overactive BladderRecruitingNCT07432659Not applicable1 country
- Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic SyndromeRecruitingNCT07563764Not applicable1 country
- Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological PopulationRecruitingNCT05949567Not applicable1 country
- Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-WetRecruitingNCT06201013Not applicable1 country
- Ambulatory Long Length URodynamics EvaluationRecruitingNCT07425015Not applicable1 country
- The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D DeficiencyNot yet recruitingNCT07513363Not applicable1 country
- Noninvasive Ultrasound Assessment of Detrusor DysfunctionRecruitingNCT056520231 country
- The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive BladderEnrolling by invitationNCT07463326Not applicable1 country
- Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MSRecruitingNCT06072703Not applicable1 country
- Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in WomenRecruitingNCT07473310Phase 41 country
- TReating Incontinence for Underlying Mental and Physical HealthRecruitingNCT05362292Phase 41 country
- Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead PlacementRecruitingNCT04527445Not applicable1 country
- Turkish USIQ: Validity & ReliabilityNot yet recruitingNCT074527961 country